logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Bone metastasis: 12-weekly bone agents are a reasonable option in breast, prostate cancer

12-weekly schedule is noninferior to 4-weekly regimen.